The current valuation score of Calidi Biotherapeutics Inc is 8.86, ranking 84 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.04, which is -12155.03% below the recent high of 4.32 and -55103.35% above the recent low of -19.76.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.